43 results
8-K
EX-99.1
CELU
Celularity Inc - Ordinary Shares
7 Sep 23
Celularity Appoints Geoffrey Shiu Fei Ling, M.D., Ph.D. to its Board of Directors
4:21pm
Significant Innovative Technology and Development Expertise Launching New Cellular Therapies
FLORHAM PARK, N.J., September 7, 2023 (GLOBE NEWSWIRE … expertise and insights to Celularity as it continues to pioneer innovative therapies for patients in need.
Throughout his career, Dr. Ling has made
8-K
EX-99.1
CELU
Celularity Inc - Ordinary Shares
29 Aug 23
Celularity Announces Multi-year Research Collaboration Services Agreement with Regeneron
9:15am
in innovative medicines.”
About Celularity
Celularity Inc. (Nasdaq: CELU) headquartered in Florham Park, N.J., is a biotechnology company leading the next … . In addition, Celularity develops, manufactures and commercializes innovative biomaterial products also derived from the postpartum placenta. Celularity believes
8-K
EX-99.1
CELU
Celularity Inc - Ordinary Shares
28 Jul 23
Celularity Inc. Announces $3 Million Registered Direct Offering
4:27pm
and degenerative diseases, and cancer. In addition, Celularity develops, manufactures, and commercializes innovative biomaterial products also derived from
8-K
EX-99.1
CELU
Celularity Inc - Ordinary Shares
31 May 23
THE NEXT EVOLUTION IN CELLULAR MEDICINE Investor Presentation June 2023
5:08pm
as typical of the outpatient setting. Deliver innovative off-the-shelf allogeneic cellular medicines and biomaterials for patients with high unmet
8-K
EX-99.1
CELU
Celularity Inc - Ordinary Shares
27 Apr 23
Other Events
5:01pm
innovative biomaterial products also derived from the postpartum placenta. Celularity believes that by harnessing the placenta’s unique biology
8-K
EX-99.1
ku640am1ia5d8
6 Apr 23
Celularity Inc. Announces $6 Million Registered Direct Offering
8:58pm
8-K
EX-99.1
w5iwb6w12x
10 Nov 22
Celularity Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:19pm
8-K
EX-99.1
3gt8uif1or
10 Aug 22
Celularity Reports Second Quarter 2022 Financial Results and Corporate Update
12:00am
8-K
EX-99.1
z32m c2c8plp153mqg
17 Jun 22
Other Events
4:57pm
424B3
lcnwlu 7s
1 Jun 22
Prospectus supplement
4:06pm
8-K
EX-99.1
m74 n7p3vguvn63835
20 May 22
Celularity Inc. Announces $30 Million Private Placement
4:06pm
8-K
EX-99.1
zrvvwt k4sg0j
16 May 22
Celularity Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:47pm
424B3
rjfiq3xx5tdz8gm
3 May 22
Prospectus supplement
4:06pm
POS AM
6xttj52ad zcdhx
1 Apr 22
Prospectus update (post-effective amendment)
9:15pm
8-K
EX-99.1
qq50jtt40
31 Mar 22
Celularity Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
4:06pm